Video Experimental Relacionado
Updated: Jan 27, 2026
02:44
Use of Micropipette-Guided Drug Administration as an Alternative Method to Oral Gavage in Rodent Models
Published on: July 26, 2024
2.7K
Sistemas inteligentes de administración de fármacos para la administración oral en el tratamiento de la EII
Jiabin Xu1,2, Peiyu Tang1,2, Xiaoyi Sun1
1School of Stomatology, Xuzhou Medical University, Xuzhou, 221004, China.
Materials today. Bio
|January 26, 2026
Resumen
Los sistemas inteligentes de administración de fármacos por vía oral ofrecen un tratamiento mejorado para la enfermedad inflamatoria intestinal (EII) al dirigirse a sitios específicos. Estos sistemas avanzados mejoran la eficacia y reducen los efectos secundarios en comparación con las terapias convencionales.
Área de la Ciencia:
- Ingeniería Biomédica
- Sistemas de administración de fármacos
- Gastroenterología
Sus antecedentes:
- La enfermedad inflamatoria intestinal (EII) es una afección global prevalente que afecta la calidad de vida del paciente.
- Las terapias orales convencionales para la EII enfrentan desafíos como la mala focalización, la absorción sistémica y la inestabilidad del fármaco, lo que lleva a una eficacia reducida y efectos adversos.
Objetivo del estudio:
- Revisar y discutir el diseño de sistemas inteligentes de administración de fármacos por vía oral para el tratamiento de la EII.
- Destacar los mecanismos, ventajas y desafíos de estas plataformas avanzadas de administración.
Principales métodos:
- Revisión de mecanismos de administración de fármacos sensibles a estímulos (desencadenantes internos y externos).
- Análisis de los hallazgos de estudios preclínicos sobre sistemas de administración inteligentes para la EII.
Principales resultados:
- Los sistemas inteligentes de administración de fármacos aprovechan estímulos internos (pH, ROS, enzimas) y externos (campos magnéticos, luz) para una liberación de fármacos precisa y localizada.
- Estos sistemas demuestran potencial para mejorar la eficacia terapéutica, minimizar la toxicidad sistémica y mejorar la adherencia del paciente.
- Los estudios preclínicos indican una promesa en la prolongación de la remisión y la promoción de la curación de la mucosa en la EII.
Conclusiones:
- Los sistemas inteligentes de administración de fármacos por vía oral representan una estrategia prometedora para superar las limitaciones de las terapias convencionales para la EII.
- Se necesita más investigación para la optimización de formulaciones, la validación clínica y la abordaje de la variabilidad interpaciente para una traslación clínica exitosa.
- El desarrollo continuo es esencial para optimizar estas plataformas avanzadas para el manejo efectivo de la EII.
Videos de Conceptos Relacionados
01:29Drugs for Treatment of Ulcerative Colitis in IBD
483
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
483
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
462
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
462
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
516
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
516
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
524
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
524
01:18Additional Routes of Drug Administration
4.7K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
4.7K
01:18Routes of Drug Administration: Enteral
6.4K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
6.4K